SCM
BLUE

Suvretta Capital Management’s bluebird bio BLUE Stock Holding History

Suvretta Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-96,699
Closed -$40.1M – 108
2021
Q2 		$40.1M Sell
96,699
-3,989
-4% -$1.58M 0.6% 43
2021
Q1 		$39.3M Buy
100,688
+67,716
+205% +$33.3M 0.58% 43
2020
Q4 		$18.5M Buy
+32,972
New +$20.9M 0.26% 53

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Suvretta Capital Management's BLUE Position: Q3 2021 in Review

Suvretta Capital Management sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 96,699 shares — an estimated $40.1M sold.

Suvretta Capital Management first reported a position in BLUE in Q4 2020 and held it in 3 quarters. The position peaked at $40.1M in Q2 2021. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

  • Suvretta Capital Management reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
  • Suvretta Capital Management sold 96,699 bluebird bio shares in Q3 2021, an estimated $40.1M.
  • Suvretta Capital Management first reported a position in bluebird bio in Q4 2020 and held it in 3 quarters.
  • Suvretta Capital Management's bluebird bio position peaked at $40.1M in Q2 2021.
  • 196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Suvretta Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.